Last reviewed · How we verify
NCT06950242: Laser balloon
Clinical Trial of Safety and Efficacy of Intracranial Laser Balloon Dilation Catheter in Patients With Symptomatic Intracranial Atherosclerotic Stenosis: A Prospective, Multi-center, Randomized Comparison
NA trial testing Balloon dilation treatment for intracranial arterial stenosis in order to improve intracranial blood supply. in Prospective, Multicenter, Randomized, Controlled, and Superior Efficiency in 128 participants. Enrolling by invitation.
30 June 2026
Quick facts
| Lead sponsor | The First People's Hospital of Changzhou |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 128 |
| Start date | 11 April 2024 |
| Primary completion | 30 June 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Balloon dilation treatment for intracranial arterial stenosis in order to improve intracranial blood supply.
- Boston Scientific Corporation
Conditions studied
- Prospective, Multicenter, Randomized, Controlled, and Superior Efficiency — all drugs for Prospective, Multicenter, Randomized, Controlled, and Superior Efficiency →
Sponsor
The First People's Hospital of Changzhou
Who can join
Adults 18 to 80, any sex, with Prospective, Multicenter, Randomized, Controlled, and Superior Efficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Experimental group：Name of Medical Apparatus ：Intracranial Laser Balloon Dilation Catheter and Laser Generator Manufacturer：Hangzhou Juzheng Medical Technology limited company
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06950242
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other The First People's Hospital of Changzhou trials
Trials by the same sponsor.
- NCT06867991 — Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis · Phase 3 · recruiting
- NCT06216340 — Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes · Phase 4 · not yet recruiting
- NCT06618222 — Wingspan Stent System for Intracranial Artery Stenosis · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06950242 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First People's Hospital of Changzhou
- Last refreshed: 30 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06950242.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing